138 related articles for article (PubMed ID: 1725233)
1. Modified-live infectious bovine rhinotracheitis virus (IBRV) vaccine expressing foot-and-mouth disease virus (FMDV) capsid protein epitopes on surface of hybrid virus particles.
Kit S; Kit M; DiMarchi R; Little S; Gale C
Adv Exp Med Biol; 1991; 303():211-20. PubMed ID: 1725233
[No Abstract] [Full Text] [Related]
2. Modified-live infectious bovine rhinotracheitis virus vaccine expressing monomer and dimer forms of foot-and-mouth disease capsid protein epitopes on surface of hybrid virus particles.
Kit S; Kit M; DiMarchi RD; Little SP; Gale C
Arch Virol; 1991; 120(1-2):1-17. PubMed ID: 1718244
[TBL] [Abstract][Full Text] [Related]
3. Bovine herpesvirus-1 (infectious bovine rhinotracheitis virus)-based viral vector which expresses foot-and-mouth disease epitopes.
Kit M; Kit S; Little SP; Di Marchi RD; Gale C
Vaccine; 1991 Aug; 9(8):564-72. PubMed ID: 1722936
[TBL] [Abstract][Full Text] [Related]
4. Characterization and immune response of a protein produced by a cDNA clone of foot and mouth disease virus, type Asia 1 63/72.
Suryanarayana VV; Venkataramanan R; Rao BU; Padayatty JD
Biochem Int; 1992 May; 26(6):1003-16. PubMed ID: 1378734
[TBL] [Abstract][Full Text] [Related]
5. Evidence of partial protection against foot-and-mouth disease in cattle immunized with a recombinant adenovirus vector expressing the precursor polypeptide (P1) of foot-and-mouth disease virus capsid proteins.
Sanz-Parra A; V Zquez B; Sobrino F; Cox SJ; Ley V; Salt JS
J Gen Virol; 1999 Mar; 80 ( Pt 3)():671-679. PubMed ID: 10092007
[TBL] [Abstract][Full Text] [Related]
6. Progress and perspectives in the development of a foot-and-mouth disease vaccine by recombinant DNA technology.
Brown F
Prog Vet Microbiol Immunol; 1987; 3():59-72. PubMed ID: 2483918
[No Abstract] [Full Text] [Related]
7. Strategy for producing new foot-and-mouth disease vaccines that display complex epitopes.
McKenna TS; Rieder E; Lubroth J; Burrage T; Baxt B; Mason PW
J Biotechnol; 1996 Jan; 44(1-3):83-9. PubMed ID: 8717390
[TBL] [Abstract][Full Text] [Related]
8. Construction and evaluation of an attenuated vaccine for foot-and-mouth disease: difficulty adapting the leader proteinase-deleted strategy to the serotype O1 virus.
Almeida MR; Rieder E; Chinsangaram J; Ward G; Beard C; Grubman MJ; Mason PW
Virus Res; 1998 May; 55(1):49-60. PubMed ID: 9712511
[TBL] [Abstract][Full Text] [Related]
9. Use of peptides for immunization against foot-and-mouth disease.
Brown F
Vaccine; 1988 Apr; 6(2):180-2. PubMed ID: 2838987
[TBL] [Abstract][Full Text] [Related]
10. Antigenic structure of foot and mouth disease virus type A22 (Indian isolates).
Tulasiram P; Suryanarayana V
Indian J Exp Biol; 1998 Jan; 36(1):70-5. PubMed ID: 9536655
[TBL] [Abstract][Full Text] [Related]
11. Construction of a recombinant BHV-1 expressing the VP1 gene of foot and mouth disease virus and its immunogenicity in a rabbit model.
Ren XG; Xue F; Zhu YM; Tong GZ; Wang YH; Feng JK; Shi HF; Gao YR
Biotechnol Lett; 2009 Aug; 31(8):1159-65. PubMed ID: 19343503
[TBL] [Abstract][Full Text] [Related]
12. Comparison of capsid protein VP1 of the viruses used for the production and challenge of foot-and-mouth disease vaccines in Spain.
González M; Mateu MG; Martínez MA; Carrillo C; Sobrino F
Vaccine; 1992; 10(11):731-4. PubMed ID: 1279905
[TBL] [Abstract][Full Text] [Related]
13. Receptor binding site-deleted foot-and-mouth disease (FMD) virus protects cattle from FMD.
McKenna TS; Lubroth J; Rieder E; Baxt B; Mason PW
J Virol; 1995 Sep; 69(9):5787-90. PubMed ID: 7637023
[TBL] [Abstract][Full Text] [Related]
14. Investigation of possible vaccine-induced epizootics of infectious bovine rhinotracheitis, using restriction endonuclease analysis of viral DNA.
Whetstone CA; Wheeler JG; Reed DE
Am J Vet Res; 1986 Aug; 47(8):1789-95. PubMed ID: 3019192
[TBL] [Abstract][Full Text] [Related]
15. Plasmid DNA encoding replicating foot-and-mouth disease virus genomes induces antiviral immune responses in swine.
Ward G; Rieder E; Mason PW
J Virol; 1997 Oct; 71(10):7442-7. PubMed ID: 9311823
[TBL] [Abstract][Full Text] [Related]
16. Protection against viral infections with the aid of synthetic peptides. Foot-and-mouth disease as an example.
Vol'pina OM; Surovoi AYu ; Ivanov VT
Biomed Sci; 1990 Jan; 1(1):23-32. PubMed ID: 1718462
[TBL] [Abstract][Full Text] [Related]
17. [Viral vaccines produced by gene technology and synthesis].
Hess RG
Tierarztl Prax; 1986; 14(1):9-14. PubMed ID: 2424142
[TBL] [Abstract][Full Text] [Related]
18. The serological response to foot-and-mouth disease vaccination is not affected by simultaneous infectious bovine rhinotracheitis/adenovirus/parainfluenza 3 vaccination.
de Clercq K; Strobbe R; van Opdenbosch E; Wellemans G; Theys H; Debecq J
Arch Exp Veterinarmed; 1989 May; 43(3):409-13. PubMed ID: 2549906
[TBL] [Abstract][Full Text] [Related]
19. [Primary structure of the gene for protein VP1 from foot-and-mouth disease virus serotype O1 isolated in the USSR].
Onishchenko AM; Petrov NA; Mamaeva NV; Kalashnikova TI; Grinev AA; Sosnovtsev SV; Degtiarev SKh; Karpyshev NN; Perevozchikova NA; Ivaniushchenkov Vn
Mol Gen Mikrobiol Virusol; 1990 Apr; (4):22-5. PubMed ID: 1694961
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of the immunity to foot-and-mouth disease virus by DNA priming and protein boosting immunization.
Shieh JJ; Liang CM; Chen CY; Lee F; Jong MH; Lai SS; Liang SM
Vaccine; 2001 Jul; 19(28-29):4002-10. PubMed ID: 11427276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
